Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

The Robert and John M. Bendheim Parkinson and Movement Disorders Center, New York

Unity Point Health, Des Moines

Raleigh Neurology Associates, Raleigh

Abington Neurological Associates, Willow Grove

Asheville Neurology Specialists, PA, Asheville

Neurology Associates of Ormond Beach, Ormond Beach

Neurology Associates, P.A., Maitland

Aventura Neurologic Associates, Aventura

JEM Research Institute, Atlantis

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

Infinity Clinical Research, Sunrise

Parkinson's Disease Treatment Center of SW Florida, Port Charlotte

University of Kentucky, Department of Neurology, Lexington

Henry Ford West Bloomfield Hospital, Bloomfield Hills

Unity Point Health, Des Moines

University of Wisconsin-Madison, Madison

University of Wisconsin - Madison, Madison

Struthers Parkinson's Center, Golden Valley

Struthers Parkinson's Center, Golden Valley

University of Kansas Medical Center, Kansas City

Movement Disorders Clinic of Oklahoma, Tulsa

Baylor College of Medicine, Houston

University of Arkansas for Medical Sciences, Little Rock

Barrow Neurology Clinics, St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix

USC, Keck School of Medicine, Los Angeles

Collaborative Neuroscience Network, LLC, Long Beach

SC3 Research Group, Pasadena

Hawaii Pacific Neuroscience, Honolulu

University of Virginia, Department of Neurology, Charlottesville

Booth Gardner Parkinson's Care Center, Kirkland

Premier Clinical Research, Spokane

Ottawa Hospital Research Institute, Ottawa

The Walton Centre NHS Foundation Trust, Neuroscience Research Center, Liverpool

Newcastle University Clinical Ageing Research Unit (CARU), Newcastle upon Tyne

The Queen Elizabeth University Hospital Department of Neurology, Glasgow